Tullis Growth Fund focuses on investing in commercial-stage healthcare companies including medical devices, healthcare services, specialty pharmaceuticals, and biotechnology, aiming to build high-margin, high-growth products and services that have a significant impact on global health.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions